Stage
Acquired Unit | AcquiredAbout Stryker - Juvenile Tumour System
On June 13th, 2022, Stryker - Juvenile Tumour System was acquired by Onkos Surgical. Terms of the transaction were not disclosed. Stryker (NYSE: SYK) is a medical technology company that offers a diverse array of products and services in Orthopedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Stryker - Juvenile Tumour System Frequently Asked Questions (FAQ)
Where is Stryker - Juvenile Tumour System's headquarters?
Stryker - Juvenile Tumour System's headquarters is located at 2825 Airview Blvd, Kalamazoo.
What is Stryker - Juvenile Tumour System's latest funding round?
Stryker - Juvenile Tumour System's latest funding round is Acquired Unit.
Who are the investors of Stryker - Juvenile Tumour System?
Investors of Stryker - Juvenile Tumour System include Onkos Surgical.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
